Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A17084 | 27999641 | Caspian J Intern Med | Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2016 | Details |
| A17087 | 27998724 | Am J Pathol | Global Deletion of Glutathione S-Transferase A4 Exacerbates Developmental Nonalcoholic Steatohepatitis. | 2016 | Details |
| A17092 | 27996033 | Sci Rep | The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy. | 2016 | Details |
| A17098 | 27993651 | Biochim Biophys Acta Mol Cell Biol Lipids | NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition. | 2016 | Details |
| A17099 | 27992443 | PLoS One | Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD. | 2016 | Details |
| A17110 | 27986627 | Eur J Pharmacol | A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models. | 2016 | Details |
| A17111 | 27986466 | Trends Endocrinol Metab | Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies. | 2016 | Details |
| A17116 | 27984176 | J Hepatol | PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis. | 2016 | Details |
| A17117 | 27982761 | Radiology | Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography. | 2016 | Details |
| A17120 | 27981809 | Mol Nutr Food Res | Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency. | 2017 | Details |
| A17121 | 27981615 | Hepatology | Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. | 2017 | Details |
| A17127 | 27977757 | PLoS One | Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial. | 2016 | Details |
| A17137 | 27967209 | Antioxid Redox Signal | Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway. | 2017 | Details |
| A17139 | 27966386 | Hematology | More on the thrombocytopenia of the non-alcoholic fatty liver disease. | 2016 | Details |
| A17150 | 27956809 | World J Gastroenterol | Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population. | 2016 | Details |
| A17151 | 27956794 | World J Gastroenterol | Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis. | 2016 | Details |
| A17152 | 27956792 | World J Gastroenterol | Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. | 2016 | Details |
| A17159 | 27941355 | Curr Opin Infect Dis | Managing nonalcoholic fatty liver disease in patients living with HIV. | 2017 | Details |
| A17160 | 27939923 | Dig Liver Dis | CD98 siRNA-loaded nanoparticles decrease hepatic steatosis in mice. | 2016 | Details |
| A17164 | 27938560 | Zhonghua Gan Zang Bing Za Zhi | [Effect of targeted inhibition of hypoxia-inducible factor-1α by 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole on the progression of non-alcoholic fatty liver disease in rats]. | 2016 | Details |
| A17165 | 27937040 | Expert Rev Gastroenterol Hepatol | Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era. | 2016 | Details |
| A17166 | 27936481 | Z Gastroenterol | Patients with ultrasound diagnosis of hepatic steatosis are at high metabolic risk. | 2016 | Details |
| A17167 | 27936280 | J Gastroenterol Hepatol | Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A17169 | 27936091 | PLoS One | Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms. | 2016 | Details |
| A17172 | 27935134 | Cell Biochem Funct | Strain- and time-dependent alterations in hepatic iron metabolism in a murine model of nonalcoholic steatohepatitis. | 2016 | Details |
| A17175 | 27930988 | Biomed Pharmacother | Potential involvement of PPAR α activation in diminishing the hepatoprotective effect of fenofibrate in NAFLD: Accuracy of non- invasive panel in determining the stage of liver fibrosis in rats. | 2016 | Details |
| A17184 | 27923447 | Metabolism | Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice. | 2016 | Details |
| A17185 | 27923446 | Metabolism | Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status. | 2016 | Details |
| A17186 | 27922486 | Eur J Gastroenterol Hepatol | The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study. | 2017 | Details |
| A17189 | 27920819 | Res Pharm Sci | Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver. | 2016 | Details |
| A17190 | 27920470 | World J Gastroenterol | Nonalcoholic fatty liver disease - A multisystem disease? | 2016 | Details |
| A17202 | 27916647 | Biochimie | PPARs and nonalcoholic fatty liver disease. | 2016 | Details |
| A17210 | 27913210 | Free Radic Biol Med | TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity. | 2016 | Details |
| A17212 | 27911262 | Gastroenterology | Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17218 | 27908400 | J Trace Elem Med Biol | Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome. | 2016 | Details |
| A17225 | 27903831 | J Nutr | Dietary Mung Bean Protein Reduces Hepatic Steatosis, Fibrosis, and Inflammation in Male Mice with Diet-Induced, Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17226 | 27903585 | Am J Physiol Cell Physiol | Autophagy in chronic liver diseases: the two faces of Janus. | 2016 | Details |
| A17237 | 27895397 | World J Gastroenterol | Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis. | 2016 | Details |
| A17238 | 27895393 | World J Gastroenterol | Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease. | 2016 | Details |
| A17248 | 27889947 | Hepatol Res | Pathological Findings of NASH and NAFLD: for Guidebook of NASH and NAFLD, 2015: The Japan Society of Hepatology. | 2017 | Details |
| A17254 | 27889556 | Int Immunopharmacol | Compact bone-derived mesenchymal stem cells attenuate nonalcoholic steatohepatitis in a mouse model by modulation of CD4 cells differentiation. | 2016 | Details |
| A17255 | 27889327 | Mol Aspects Med | Epigenetics in non-alcoholic fatty liver disease. | 2016 | Details |
| A17256 | 27889186 | Cancer Cell | Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis. | 2016 | Details |
| A17261 | 27881858 | Int J Obes (Lond) | Safety and efficacy of bariatric surgery in patients with advanced fibrosis. | 2016 | Details |
| A17265 | 27880977 | Hepatology | Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis. | 2017 | Details |
| A17272 | 27872651 | Evid Based Complement Alternat Med | A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17275 | 27869416 | Arch Argent Pediatr | Non-alcoholic fatty liver disease: a new epidemic in children. | 2016 | Details |
| A17282 | 27863346 | J Nutr Biochem | A diet-induced Sprague-Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis. | 2016 | Details |
| A17287 | 27862719 | Hepatol Res | Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression. | 2016 | Details |
| A17288 | 27862590 | J Magn Reson Imaging | Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we? | 2016 | Details |
| A17290 | 27862096 | Aliment Pharmacol Ther | Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis. | 2016 | Details |
| A17296 | 27859583 | J Gastroenterol Hepatol | External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients. | 2017 | Details |
| A17298 | 27859470 | Aliment Pharmacol Ther | Non-alcoholic fatty liver diseases and risk of colorectal neoplasia. | 2016 | Details |
| A17312 | 27853271 | Sci Rep | Foetal programming by methyl donor deficiency produces steato-hepatitis in rats exposed to high fat diet. | 2016 | Details |
| A17318 | 27851786 | PLoS One | Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles. | 2016 | Details |
| A17331 | 27837778 | Gastroenterol Clin North Am | Nonalcoholic Fatty Liver Disease: Pathophysiology and Management. | 2016 | Details |
| A17332 | 31435207 | J Taibah Univ Med Sci | The role of elevated alanine aminotransferase (ALT), FasL and atherogenic dyslipidemia in type II diabetes mellitus. | 2016 | Details |
| A17333 | 27837387 | Obes Surg | Vitamin D3 Loading Is Superior to Conventional Supplementation After Weight Loss Surgery in Vitamin D-Deficient Morbidly Obese Patients: a Double-Blind Randomized Placebo-Controlled Trial. | 2017 | Details |
| A17334 | 27836992 | J Lipid Res | Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study. | 2016 | Details |
| A17335 | 27836788 | Chem Biol Interact | Regression of fibrosis/cirrhosis by Glycine propionyl-l-carnitine treatment in d-Galactosamine induced chronic liver damage. | 2016 | Details |
| A17340 | 27834813 | Biology (Basel) | The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease. | 2016 | Details |
| A17343 | 27833386 | World J Gastroenterol | Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry. | 2016 | Details |
| A17351 | 27830836 | Sci Rep | Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial. | 2016 | Details |
| A17359 | 27824642 | Eur J Gastroenterol Hepatol | Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2017 | Details |
| A17368 | 27822476 | Biomed Res Int | Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells. | 2016 | Details |
| A17372 | 27821715 | Physiol Rep | A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis. | 2016 | Details |
| A17373 | 27821024 | Acta Gastroenterol Belg | Predictive value of neutrophiltolymphocyte ratio in the severity of non-alcoholic fatty liver disease among type 2 diabetes patients. | 2017 | Details |
| A17382 | 27813192 | Clin Exp Pharmacol Physiol | Naltrexone changes the expression of lipid metabolism-related proteins in the endoplasmic reticulum stress induced hepatic steatosis in mice. | 2017 | Details |
| A17386 | 27810989 | Diabetes Care | Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference. | 2016 | Details |
| A17396 | 27644736 | Am J Gastroenterol | Vitamin D is Not Associated With Severity in NAFLD: Results of a Paired Clinical and Gene Expression Profile Analysis. | 2016 | Details |
| A17409 | 27797398 | Eur J Clin Invest | Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis. | 2016 | Details |
| A17410 | 27796814 | Endocrine | Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease. | 2016 | Details |
| A17412 | 27796056 | J Gastroenterol Hepatol | Systematic review: Current evidence in non-alcoholic fatty liver disease lacks relevance to patients with advanced fibrosis. | 2017 | Details |
| A17413 | 27795938 | Curr Hepatol Rep | Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17418 | 27794176 | Hepatol Res | High fasting insulin concentrations may be a pivotal predictor for the severity of hepatic fibrosis beyond the glycemic status in non-alcoholic fatty liver disease patients before development of diabetes mellitus. | 2016 | Details |
| A17432 | 27710160 | Metab Syndr Relat Disord | Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans. | 2016 | Details |
| A17434 | 27613872 | J Biol Chem | Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin. | 2016 | Details |
| A17436 | 27569726 | Gastroenterology | In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores. | 2016 | Details |
| A17437 | 27539017 | Hepatol Res | Liver stiffness measurement to platelet ratio index predicts the stage of liver fibrosis in non-alcoholic fatty liver disease. | 2016 | Details |
| A17443 | 27743352 | Adv Ther | Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design. | 2016 | Details |
| A17454 | 27603289 | AIDS | Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients. | 2016 | Details |
| A17457 | 27778429 | Liver Int | Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity. | 2017 | Details |
| A17459 | 27778367 | Aliment Pharmacol Ther | Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis. | 2016 | Details |
| A17461 | 27777925 | Can J Gastroenterol Hepatol | The Effect of Bariatric Surgery on the Spectrum of Fatty Liver Disease. | 2016 | Details |
| A17471 | 27773935 | Acta Pharmacol Sin | Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation. | 2016 | Details |
| A17475 | 27699993 | Liver Int | Transient elastography for the diagnosis of liver fibrosis: a systematic review of economic evaluations. | 2016 | Details |
| A17480 | 27522549 | Dig Liver Dis | Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study. | 2016 | Details |
| A17499 | 27543837 | Hepatology | The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. | 2016 | Details |
| A17501 | 27315352 | Hepatology | Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study. | 2016 | Details |
| A17502 | 27301788 | Hepatology | Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury. | 2016 | Details |
| A17506 | 27098507 | Diabetes Metab J | Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice. | 2016 | Details |
| A17509 | 27764892 | Pediatr Obes | Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease. | 2016 | Details |
| A17511 | 27762491 | Pediatr Transplant | Resolution of non-alcoholic steatohepatitis after growth hormone replacement in a pediatric liver transplant patient with panhypopituitarism. | 2016 | Details |
| A17519 | 27759627 | Medicine (Baltimore) | Thiazolidinediones for nonalcoholic steatohepatitis: A meta-analysis of randomized clinical trials. | 2016 | Details |
| A17523 | 27757953 | J Pathol | Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances. | 2016 | Details |
| A17526 | 27756518 | Nutr Metab Cardiovasc Dis | Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications. | 2016 | Details |
| A17528 | 27717115 | J Sci Food Agric | Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation. | 2016 | Details |
| A17536 | 27521509 | Clin Gastroenterol Hepatol | Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial. | 2016 | Details |
| A17541 | 27753194 | Hepatol Res | Assessment of transient elastography in Japanese patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A17546 | 27577682 | J Pathol | Mitochondrial genome architecture in non-alcoholic fatty liver disease. | 2016 | Details |